Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Aniline-PEG3-C1-Boc

Aniline-PEG3-C1-Boc (compound D-1) is an intermediate of cytotoxic drug linker polymer. Aniline-PEG3-C1-Boc can be used in the synthesis of antibody-drug conjugates (ADCs) [1].

Product Specifications

CAS Number

[2115897-27-1]

UNSPSC

12352203

Target

Drug-Linker Conjugates for ADC

Type

ADC Related

Related Pathways

Antibody-drug Conjugate/ADC Related

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/aniline-peg3-c1-boc.html

Purity

98.26

Solubility

DMSO : 350 mg/mL (ultrasonic)

Smiles

O=C(COCCOCCOCCOC1=CC=C(C=C1)N)OC(C)(C)C

Molecular Formula

C18H29NO6

Molecular Weight

355.43

References & Citations

[1]JingKang Shen, et al. Antibody-drug conjugate targeting CD73 and preparation method and application thereof. China, CN110575548A.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C, 3 years (Powder)

Scientific Category

ADC Related

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

PITPNM1 (Phosphatidylinositol transfer Protein, Membrane-Associated 1, DRES9, FLJ44997, NIR2, PITPNM, RDGB, RDGB1, RDGBA, RDGBA1, Rd9)
250135 50 µL

PITPNM1 (Phosphatidylinositol transfer Protein, Membrane-Associated 1, DRES9, FLJ44997, NIR2, PITPNM, RDGB, RDGB1, RDGBA, RDGBA1, Rd9)

Ask
View Details
AZ-33
530396 100.0mg

AZ-33

Ask
View Details
LRRC2 (Leucine-rich Repeat-Containing Protein 2, LRRC2) (PE) discontinued
302540-PE 200 µL

LRRC2 (Leucine-rich Repeat-Containing Protein 2, LRRC2) (PE) discontinued

Ask
View Details
KCNJ4 Antibody (N-term)
MBS9206063-01 0.08 mL

KCNJ4 Antibody (N-term)

Ask
View Details
KCNJ4 Antibody (N-term)
MBS9206063-02 0.4 mL

KCNJ4 Antibody (N-term)

Ask
View Details
KCNJ4 Antibody (N-term)
MBS9206063-03 5x 0.4 mL

KCNJ4 Antibody (N-term)

Ask
View Details